These compounds may interact with:
Nuclear receptor coactivator 3
Potentially involved in: osteoarthritis; leukemia; kidney cancer; carcinoma; cancer; adenocarcinoma; astrocytoma; bone neoplasms; non-small cell lung carcinoma; squamous cell carcinoma; prostatic neoplasms; mammary neoplasms; astrocytic glioma; atypical teratoid / rhabdoid tumor; chronic lymphocytic leukemia; crohn's disease; ependymoma; glioblastoma; intraductal papillary-mucinous neoplasm (ipmn); lung cancer
Disease data sourced from Pharos.